RedHill Biopharma Announces Positive DSMB Futility Review for Phase 2/3 COVID-19 Study of Opaganib
TEL AVIV, Israel and RALEIGH, N.C., Jan. 29, 2021 /PRNewswire/ -- RedHill
Biopharma Ltd.
RedHill Biopharma Further Expands Opaganib Manufacturing Capacity for COVID-19 with Cosmo Pharmaceuticals
TEL AVIV, Israel and RALEIGH, N.C., Jan. 28, 2021 /PRNewswire/ -- RedHill
Biopharma Ltd.
"Right to Work" Is Theme of 16th Global Appeal to End Stigma and Discrimination against Persons Affected by Leprosy to Be Launched with Endorsement of International Trade Union Confederation
TOKYO and BRUSSELS, Jan. 28, 2021 /PRNewswire/ -- The 16th Global Appeal to End Stigma and Discrimi...
European Commission Approves BAVENCIO® (avelumab) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
- BAVENCIO maintenance treatment significantly extended median overall survival versus standard of ...
Sasakawa Leprosy (Hansen's Disease) Initiative Generates Awareness in Buildup to World Leprosy Day 2021
TOKYO, Jan. 21, 2021 /PRNewswire/ -- With the approach of World Leprosy Day on January 31, 2021, Sa...
Merck Announces Update on the INTR@PID Clinical Program Including Lung 037 Study
DARMSTADT, Germany, Jan. 20, 2021 /PRNewswire/ -- Not intended for US-, Canada- or UK-based media ...
RedHill Biopharma Announces Positive Top-Line Safety and Efficacy Data from Phase 2 COVID-19 Study of Opaganib
Preliminary data from the non-powered U.S. Phase 2 study of 40 hospitalized patients shows that ora...
Enhancing Customer Experience with Innovative Technologies
SHANGHAI, Dec. 17, 2020 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China", NYS...
BAVENCIO® (avelumab) Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Not intended for US-, Canada- and UK-based media DARMSTADT, Germany and NEW YORK, Dec. 11, 2020 /P...
Global Korea Convention opens to spotlight Seoul's achievements in int'l cooperation
SEOUL, South Korea, Dec. 9, 2020 /PRNewswire/ -- An international forum kicked off inSeoul on Wedne...
New Report: 4 Key Factors to Successfully Attract and Retain Vietnam's Gen Z in the Workplace
HO CHI MINH CITY, Vietnam, Nov. 26, 2020 /PRNewswire/ -- By 2025, Gen Z (those born between 1997 to...
RedHill Biopharma Completes Enrollment for COVID-19 U.S. Phase 2 Study with Opaganib - Data Expected in the Coming Weeks
Enrollment completed in the U.S. Phase 2 study evaluating opaganib's safety and initial efficacy si...
Merck to Collaborate with Donghao Lansheng to Pilot New Import Policy in China
* Merck is first international company to pilot the new custom clearance process SHANGHAI, Nov. 8...
WeBank's Accessible App Makes Online Banking Easier for Visually Impaired Citizens in China
SHENZHEN, China, Oct. 19, 2020 /PRNewswire/ -- On 15 October, White Cane Safety Day, WeBank, the fi...
JinkoSolar Announces Second Quarter 2020 Financial Results
SHANGRAO, China, Sept. 23, 2020 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "...
Campaign Urges Governments at Next Year's UN Climate Conference to Back Compulsory Climate Education and Literacy
Urgent Action Needed to Equip All Youth with the Knowledge and Skills Needed to Join Green Economy ...
UN75 Dialogue - Family Mask and its #BackToSchool Initiative for Global Goals Week 2020
HONG KONG, Sept. 21, 2020 /PRNewswire/ -- To celebrate United Nations and its 75 th anniversary, Fam...
BAVENCIO Pivotal Phase III JAVELIN Bladder 100 Results Published in The New England Journal of Medicine
Not intended for US-, Canada- and UK-based media DARMSTADT, Germany, and NEW YORK, Sept. 18, 2020 ...
Unique International Conference to Examine Building a Better Board
HONG KONG, Sept. 14, 2020 /PRNewswire/ -- The art and science behind building the best-possible boa...
Merck Advances Oncology Portfolio and Pipeline with New and Long-term Data in Multiple Cancers at ESMO 2020
* New analyses from Phase III JAVELIN Bladder 100 study of BAVENCIO®* assess efficacy across subg...